Your session is about to expire
← Back to Search
Device
Comparison for patients of lumbar drain and shunt surgery for Normal Pressure Hydrocephalus (NPH Trial)
N/A
Waitlist Available
Led By Laura Pare, MD, FRCSC
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 min per clinic visit
Awards & highlights
No Placebo-Only Group
Summary
The research project is designed to determine which combination of tests will enable physicians to predict whether a patient with symptoms of normal pressure hydrocephalus (NPH) will improve with a shunt.
Eligible Conditions
- Normal Pressure Hydrocephalus
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ initial and follow-up visits
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~initial and follow-up visits
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Evans Ratio
Secondary study objectives
Physical Therapy, Occupational Therapy, and Speech Therapy
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Comparison for patients of lumbar drain and shunt surgeryExperimental Treatment2 Interventions
Subjective comparisons made for patients - before and after external lumbar drain, before and after shunt surgery.
Device: Programmable Shunt Insertion (Codman Medtronic)
Behavioral: Assessments in physical therapy, occupational therapy, and speech therapy
Follow-up testing to be administered by trained physician assistant in the outpatient setting on an approximately monthly basis: 10m walk, timed up-and-go, mini-mental status exam, 9-hole grooved pegboard, motor visual perception test (MVPT), modified rankin score (MRS)
Find a Location
Who is running the clinical trial?
University of California, IrvineLead Sponsor
565 Previous Clinical Trials
1,932,934 Total Patients Enrolled
Laura Pare, MD, FRCSCPrincipal InvestigatorUC Irvine
Share this study with friends
Copy Link
Messenger